New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity.

Auvelity preliminary 4Q and full year 2024 net product sales of $92.6 million and $291.4 million, respectivelySunosi preliminary 4Q and full year ...

We delivered strong revenue growth in 2024 and significantly advanced our industry leading neuroscience pipeline, including achievement of ...

Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced that its affiliate Nuvo Pharmaceuticals (Ireland) DAC has acquired the United States rights to PROVIGIL ...